Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans

Cited by (982)

Items 801–900 of 982

1. High conservation level of CD8+ T cell immunogenic regions within an unusual H1N2 human influenza variant
   Naomi Komadina, Sergio M. Quiñones‐Parra, Katherine Kedzierska, James M. McCaw, Anne Kelso, Karin S Leder, Jodie McVernon · 2016 · Journal of Medical Virology
2. Novel IFN-γ ELISpot reveals robust T cell responses elicited after influenza nucleoprotein DNA vaccination in New Zealand White rabbits
   Bryan S. Yung, Holly M. Pugh, Alison Generotti, Nikki Phanhthilath, Katherine Schultheis, Kar Muthumani, Kate E. Broderick, Trevor R.F. Smith · 2019 · Vaccine
3. Longitudinal Profiling of Cytokines and Chemokines in COVID-19 Reveals Inhibitory Mediators IL-1Ra and IL-10 Are Associated with Disease Severity While Elevated RANTES Is an Early Predictor of Mild Disease
   Yan Zhao, Ling Qin, Ping Zhang, Kang Li, Lianchun Liang, Jianping Sun, Bin Xu, Yanchao Dai, Xuemei Li, Chi Zhang et al. · 2020 · SSRN Electronic Journal
4. Preexisting vaccine-primed heterosubtypic T cell immunity protects the maternal-fetal unit from adverse influenza outcomes in mice
   Valeria Flores-Malavet, Kunal Dhume, Ali Satchmei, Andrea C. Arvelo, Aaron J. Beaird, Siva N. Annamalai, Lauren A. Kimball, Karl Kai McKinstry, Tara M. Strutt · 2025 · Journal of Clinical Investigation
5. Preclinical evaluation of an mRNA vaccine developed from the first human isolate of bovine H5N1
   Hongli Li, Mengting Huang, Simin Feng, Wansheng Li, Dandan Wei, Xuechun Li, Yun Quan, Hao Shuang Gu, Ting Jiang, Yan Liu et al. · 2026 · Cell Reports Medicine
6. Heterologous DNA–Adenovirus Prime–Boost Strategy Expressing Bluetongue Virus VP2 and VP7 Proteins Protects Against Virulent Challenge
   Pablo Nogales‐Altozano, Laro Gómez‐Marcos, Ana Belén Carlón, Andrés Louloudes-Lázaro, Alicia Rivera-Rodríguez, Jaime Larraga, Pedro J. Alcolea, Ana Alonso, Vicente Larraga, Verónica Martı́n et al. · 2025 · Vaccines
7. Abortive infection: T cells as early, antibody-independent defenders
   Leo Swadling, Valeria Fumagalli, Mala K. Maini, Matteo Iannacone · 2026 · Nature reviews. Immunology
8. Influensavaksine – til hvem?
   Bjørn Haneberg, Svenn‐Erik Mamelund, Siri Mjaaland · 2013 · Tidsskrift for Den norske legeforening
9. Human Innate Lymphoid Cells in Influenza Infection and Vaccination
   Amrita Kumar, Rashmi Kumari, Timothy Liu, Weiping Cao, Bruce A. Davidson, Paul R. Knight, Suryaprakash R. Sambhara · 2021 · Critical Reviews in Immunology
10. The Potential for Twice‐Annual Influenza Vaccination to Reduce Disease Burden
    Shuyi Zhong, Mark G. Thompson, Benjamin John Cowling · 2025 · Influenza and Other Respiratory Viruses
11. Aging and Viral Evolution Impair Immunity Against Dominant Pan‐Coronavirus‐Reactive T Cell Epitope
    Lucie Loyal, Karsten Jürchott, Ulf Reimer, Lil Meyer‐Arndt, Larissa Henze, Norbert Mages, Jak Kostrzanowski, Bernhard Reus, Maike Mangold, Beate Kruse et al. · 2025 · European Journal of Immunology
12. Immunogenicity as a Predictor of Influenza Vaccine Efficacy: A Systematic Review
    André Miguel Martins, Luis Félix Valero Juan, Marlene Santos, João Paulo Martins · 2025 · Vaccines
13. Comparative analysis of cellular immune responses to four seasonal inactivated influenza vaccines in younger and older adults
    Vanessa Silva‐Moraes, Laise Rodrigues Reis, Ted M. Ross · 2025 · The Journal of Immunology
14. Antibody persistence and serological protection among seasonal 2007 influenza A(H1N1) infected subjects: Results from the FLUREC cohort study
    Rosemary Markovic Delabre, Nicolas Salez, Magali Lemaître, Marianne Leruez‐Ville, Xavier Nicolas de Lamballerie, Fabrice Carrat · 2015 · Vaccine
15. Universal Influenza Vaccine Design: Directing the Antibody Repertoire
    Freek Cox, Jarek Juraszek, Esther J. M. Stoop, Jaap Goudsmit · 2016 · Future Virology
16. Impact of prior infection and repeated vaccination on post-vaccination antibody titers of the influenza A(H1N1)pdm09 strain in Taiwan schoolchildren: Implications for public health
    Wei Yong Liu, Yu-Hui Lien, Ping‐Ing Lee, Ta‐Chien Chan, Lih‐Chiann Wang, Chin-Rur Yang, Mei‐Shang Ho, Juine-Ruey Chen, Chia‐Chi Ku, Chwan‐Chuen King · 2022 · Vaccine
17. A Brief History of Human Challenge Studies (1900–2021) Emphasising the Virology, Regulatory and Ethical Requirements, Raison D’etre, Ethnography, Selection of Volunteers and Unit Design
    JOHN S. OXFORD, A. Catchpole, Anita Mann, Alan Bell, Nicolas Noulin, D. Gill, JOHN S. OXFORD, Anthony Gilbert, Shobana Balasingam · 2022 · Current topics in microbiology and immunology
18. Flagellin-Fused Protein Targeting M2e and HA2 Induces Innate and T-Cell Responses in Mice of Different Genetic Lines
    Liudmila A. Stepanova, Marina A. Shuklina, K. A. Vasiliev, Anna A. Kovaleva, Inna G. Vidyaeva, Yana A. Zabrodskaya, Alexandr V. Korotkov, Liudmila M. Tsybalova · 2022 · Vaccines
19. Timing of Assessment of Humoral and Cell-Mediated Immunity after Influenza Vaccination
    Naruhito Otani, Kazuhiko Nakajima, Kumiko Yamada, Kaori Ishikawa, Kaoru Ichiki, Takashi Ueda, Yoshio Takesue, Takuma Yamamoto, Satoshi Higasa, Susumu Tanimura et al. · 2024 · Vaccines
20. The role of cellular immunity in Influenza H1N1 population dynamics
    Venkata R. S. K. Duvvuri, Jane Marie Heffernan, Seyed M. Moghadas, Bhargavi Duvvuri, Hongbin Guo, David N. Fisman, Jianhong Wu, Gillian E. Wu · 2012 · BMC Infectious Diseases
21. Immune Function
    Marian L. Kohut · 2016 · American Journal of Lifestyle Medicine
22. High Prevalence of Humoral and Cellular Immunity to Influenza Viruses in Preschool Children Living in Addis Ababa, Ethiopia
    Jennifer Lynn Dembinski, Adane Mihret, Solomon Abebe Yimer, Bamlak Tessema, Mai-Chi Trieu, Azeb Tarekegn, Nahom Getachew, Rebecca Jane Cox, Fredrik Oftung, Bjørn Haneberg et al. · 2017 · Open Forum Infectious Diseases
23. Immune Responses to Viral Infection
    Hendrik Streeck, Todd J. Suscovich, Galit Alter · 2016 · ASM Press eBooks
24. Immunity to Influenza. Preventing Infection and Regulating Disease
    Emma Kaitlynn Allen, Paul Glyndwr Thomas · 2015 · American Journal of Respiratory and Critical Care Medicine
25. Challenges in the development of T-cell–based universal influenza vaccines
    Jung-Ok Kang, Jun Chang · 2017 · Clinical and Experimental Vaccine Research
26. Large clones of pre-existing T cells drive early immunity against SARS-COV-2 and LCMV infection
    Martina Milighetti, Yanchun Peng, Cedric C.S. Tan, Michal Mark, Gayathri Nageswaran, Suzanne Byrne, Tahel Ronel, Tom Peacock, Andreas Mayer, Aneesh Chandran et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
27. Early antiviral CD4 and CD8 T cell responses and antibodies are associated with upper respiratory tract clearance of SARS-CoV-2
    Sydney I. Ramirez, Paul G. Lopez, Farhoud Faraji, Urvi M. Parikh, Amy Heaps, Justin Ritz, Carlee Moser, Joseph J. Eron, David Alain Wohl, Judith S. Currier et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
28. Seasonal Influenza Exposure Elicits Functional Antibody and T-cell Responses to A(H5) Influenza Viruses in Humans
    Mark A. Power, Willemijn F. Rijnink, Widia Soochit, Lennert Gommers, Anne van der Linden, Felicity D. Chandler, Femke Volker, Theo M. Bestebroer, Babs E. Verstrepen, Alba Grifoni et al. · 2025 · medRxiv
29. Manning the Barricades: Lung Fibroblasts and CD4+ T Cells as the Last Line of Defense against Bacterial Invasion?
    Andrew J. Hutton, Jane A. Warner, Karl J. Staples · 2018 · Critical Reviews in Immunology
30. T cell-mediated protection in absence of virus neutralizing antibodies
    Yeranddy Aguiar Alpizar, Kai Dallmeier · 2025 · Nature Microbiology
31. Intranasal vaccine induces broad and long-lasting immunity against the hemagglutinin stem of group 2 influenza A viruses
    Wanyue Zhang, Jérémie Prévost, Angela M Sloan, Levi A. Tamming, Annabelle Pfeifle, Caroline Gravel, Sathya N. Thulasi Raman, Gary Van Domselaar, Michael Johnston, Lisheng Wang et al. · 2025 · Antiviral Research
32. Chimeric Virus-like Particles Formed by the Coat Proteins of Single-Stranded RNA Phages Beihai32 and PQ465, Simultaneously Displaying the M2e Peptide and the Stalk HA Peptide from Influenza a Virus, Elicit Humoral and T-Cell Immune Responses in Mice
    Egor A. Vasyagin, Anna A. Zykova, Elena A. Blokhina, Olga O. Ozhereleva, Liudmila A. Stepanova, Marina A. Shuklina, Sergey A. Klotchenko, Eugenia S. Mardanova, Nikolai V. Ravin · 2025 · Vaccines
33. High-dose influenza vaccine: enhanced protection for the elderly
    Claudia Maria Trombetta, Emanuele Montomoli · 2025 · Expert Review of Vaccines
34. Dynamical analysis of a tumor model with immunotherapy treatment
    Ruchita Amin, Pei Yu · 2025 · Chaos Solitons & Fractals
35. Epitope specificity shapes the CD4+ T-cell response to influenza virus infection in mice
    Daiki Mori, Nicolas Sax, Nozomi Shimada, Mana Kuwabara, Isao Ebina, Ryusuke Omiya, Kunihiro Hattori, Ryo Shinnakasu, Kazuo Yamashita, Sho Yamasaki et al. · 2026 · International Immunology
36. CD4+ T cell-mediated immunity protects from VSV-SUD lethal challenge in a mouse model of Sudan virus infection
    Lara Kelchtermans, Katrien Geerts, Cuong Thi Pham, Vanshika Malviya, Winston Chiu, Carolien De Keyzer, Elias Broeckhoven, Johan H. Neyts, Susan Schlenner, Yeranddy Aguiar Alpizar et al. · 2026 · Nature Immunology
37. Characterisation of immune responses targeting highly pathogenic avian influenza A(H5) viruses in health-care workers in the Netherlands: an observational, cross-sectional analysis
    Mark A. Power, Willemijn F. Rijnink, Widia Soochit, Lennert Gommers, Anne van der Linden, Felicity D. Chandler, Femke Volker, Theo M. Bestebroer, Babs E. Verstrepen, Alba Grifoni et al. · 2026 · The Lancet Microbe
38. Проблема создания универсальной противогриппозной вакцины
    Andrej Egorov · 2016 · Microbiology Independent Research Journal (MIR Journal)
39. Immune Responses to Persistent or Recurrent Antigens: Implications for Immunological Memory and Immunotherapy
    2021 · Frontiers research topics
40. Inactivated and Recombinant Influenza Vaccines
    Manish M. Patel, Lisa A. Grohskopf, Suryaprakash R. Sambhara, Jessica A. Belser, Jacqueline M. Katz, Alicia M. Fry · 2023 · Elsevier eBooks
41. Pandemic H1N1 influenza virus triggers a strong T helper cell response in human nasopharynx-associated lymphoid tissues
    Waleed H. Mahallawi, Omar Falah Khabour · 2024 · Saudi Journal of Biological Sciences
42. The Memory-CD8+-T-Cell Response to Conserved Influenza Virus Epitopes in Mice Is Not Influenced by Time Since Previous Infection
    Josien Lanfermeijer, Koen van de Ven, Marion Hendriks, Harry van Dijken, Stefanie Lenz, Martijn W. Vos, José A. M. Borghans, Debbie van Baarle, Jørgen de Jonge · 2024 · Vaccines
43. Inno4Vac Workshop Report Part 2: RSV‐Controlled Human Infection Model (CHIM) Strain Selection and Immune Assays for RSV CHIM Studies, November 2021, MHRA, UK
    Joanna Waldock, Rebecca Jane Cox, Othmar G. Engelhardt, Stephanie Ascough, Albert D. M. E. Osterhaus, Guus F. Rimmelzwaan, Martin Ludlow, John S. Tregoning, Jacqueline U. McDonald, Ursula J. Buchholz et al. · 2024 · Influenza and Other Respiratory Viruses
44. Roads to advanced vaccines: influenza case study
    Peggy Riese, Carlos A. Guzmán · 2017 · Microbial Biotechnology
45. Influenza Vaccine—Live
    Catherine J. Luke, Seema S. Lakdawala, Kanta Subbarao · 2017 · Elsevier eBooks
46. Acquired immune responses to the seasonal trivalent influenza vaccination in COPD
    Karl J. Staples, N P Williams, Olivia Bonduelle, Andrew J. Hutton, Doriana Cellura, Anthony C. Marriott, Béhazine Combadière, Tom M. A. Wilkinson · 2019 · Clinical & Experimental Immunology
47. Immunosenescence Modulation by Vaccination
    Janet E. McElhaney · 2019 · Springer eBooks
48. In vitro modeling of the interaction between human epithelial cells and lymphocytes upon influenza infection
    Natalia A. Ilyushina, Peter F. Wright · 2016 · Influenza and Other Respiratory Viruses
49. The Influenza Vaccine Mess
    Stanley Alan Plotkin · 2018 · Journal of the Pediatric Infectious Diseases Society
50. The Mucosal Immune Response to Respiratory Viruses
    Bart N. Lambrecht, Katrijn Neyt, Mary J. G. van Helden · 2015 · Elsevier eBooks
51. The Ferret in Viral Respiratory Disease Research
    Deborah R. Taylor · 2014
52. Significant control of Zika infection in macaques depends on the elapsing time after dengue exposure
    Crisanta Serrano-Collazo, Erick X. Pérez-Guzmán, Petraleigh Pantoja, Mariah Hassert, Idia V. Rodríguez, Luis David Giavedoni, Vida L Hodara, Laura M. Parodi, Lorna A. Cruz, Teresa Arana et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
53. Lung-Resident Memory CD8+ T Cells in Human Influenza: How Innate Are They?
    Thi H. O. Nguyen, Katherine Kedzierska · 2021 · American Journal of Respiratory and Critical Care Medicine
54. Precast concrete wall-foundation connection. Development of a seismic dissipative connection
    Rui Marreiros · 2014 · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
55. Successive annual influenza vaccination induces a recurrent oligoclonotypic memory response in circulating T follicular helper cells
    RS Herati, Alexander Muselman, Laura A. Vella, B Bengsch, Kaela Parkhouse, D Del Alcazar, J Kotzin, SA Doyle, P Tebas, SE Hensley et al. · 2018 · immuneACCESS
56. Inflammation durably imprints memory CD4+ T cells
    Sophie L. Gray-Gaillard, Sabrina M. Solis, Han M. Chen, Clarice Monteiro, Grace O. Ciabattoni, Marie I. Samanovic, Amber R. Cornelius, Tijaana Williams, Emilie Geesey, Miguel Rodriguez et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
57. Long-term respiratory mucosal immune memory to SARS-CoV-2 after infection and vaccination
    Elena Mitsi, Mariana O. Diniz, Jesús Reiné, Andrea M. Collins, Ryan Robinson, Angela D. Hyder-Wright, Madlen Farrar, Konstantinos Liatsikos, Josh Hamilton, Onyia Onyema et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
58. Development of a multi-epitope peptide vaccine against human leishmaniases
    Joana Pissarra · 2019
59. Quantifying the Persistence of Vaccine-Related T Cell Epitopes in Circulating Swine Influenza A Strains from 2013–2017
    Swan Tan, Andrés H. Gutiérrez, Phillip Charles Gauger, Tanja Opriessnig, Justin Bahl, Leonard Moise, Anne Searls De Groot · 2021 · Vaccines
60. Influence of disease attenuation on relative influenza vaccine effectiveness by vaccine type
    Jill M. Ferdinands, Manish M. Patel · 2022 · Vaccine
61. Influenza Viruses
    John J. Treanor · 2023 · Springer eBooks
62. Influenza Vaccine—Live
    Richard G. Pebody, Kanta Subbarao · 2023 · Elsevier eBooks
63. T cell responses to SARS-COV-2
    Laiqha Khadri, Mohammad Hossein Ziraksaz, Ahmad Bashir Barekzai, Baber Ghauri · 2023 · Progress in molecular biology and translational science
64. The role of influenza Hemagglutination-Inhibition antibody as a vaccine mediator in children
    Shahrzad Motaghi, Eleanor Pullenayegum, Rebecca L. Morgan, Mark B Loeb · 2024 · Vaccine
65. Evaluation of Humoral and Cell-Mediated Immunity Induced by Quadrivalent Influenza Vaccine in Pre-COVID-19 Japan
    Naruhito Otani, Toshiomi Okuno, Kumiko Yamada, Toshie Tsuchida, Kaori Ishikawa, Kaoru Ichiki, Takashi Ueda, Yoshio Takesue, Satoshi Higasa, Kazuhiko Nakajima · 2025 · Viruses
66. High CD4⁺ T-cell responses in seronegative individuals following SARS-CoV-2 exposure during a dormitory outbreak
    Ooiean Teng, Amy M.L. Quek, Delicia Shu Qin Ooi, Suqing Wang, Lorivie Fragata, Isabel Xue Qi Ng, Jianzhou Cui, Jinmiao Chen, Mikael Hartman, Paul Edward Hutchinson et al. · 2025 · International Journal of Infectious Diseases
67. Novel Mini‐Hemagglutinin Subunit Vaccine Induces Robust Mucosal and Systemic Immunity and Protection Against a Lethal Challenge With the H1N1 and H5N1 Influenza Viruses in Mice
    Tangqi Wang, Ruiwen Han, Jia Li, Xueting Cheng, Zhenyong Qi, Jialuo Bing, Chengcheng Zhai, Donghong Wang, Yao Deng, Wenjie Tan · 2025 · Journal of Medical Virology
68. Cell-based immune anticipation of the omicron variant in SARS-CoV-2 triple-vaccinated cancer patients
    Mario Mairhofer, Lea Kausche, Sabine Kaltenbrunner, Maria Pammer, Riad Ghanem, Maike Stegemann, Clemens A. Schmitt · 2025 · iScience
69. Adjuvanted Recombinant Hemagglutinin Vaccine Provides Durable and Broad-Spectrum Immunogenicity in Mice
    Rui Yu, Yan Guo, Senyan Zhang, Yuanbao Ai, Rui Wei, Yan Li, Hang Chen, Shuyun Liu, Caixia Zhang, Yuanfeng Yao et al. · 2025 · Vaccines
70. T cell immunity to seasonal Influenza A and H5N1 viruses in laboratory workers receiving annual seasonal Influenza vaccines
    Joel Sop, Tyler P. Beckey, Lizeth Gutierrez, Li Zhang, Kelly A. Gebo, Kellie Nicole Smith, Joel N. Blankson · 2025 · Frontiers in Immunology
71. Influenza vaccination post-COVID-19 expands vaccine-specific effector CD4 T-cells and Tregs under positive influence of host trained innate immunity
    Hima Bindhu, Srabanti Rakshit, Vasista Adiga, Asma Sirageldin Ahmed, Nirutha Chetan Kumar, Maria Macrina, Himanshu Tripathi, Francesca Vanni, Emanuele Montomoli, Sweety Samal et al. · 2025 · npj Vaccines
72. Meeting Report: Fourth Correlates of Protection for Next Generation Influenza Vaccines
    Alina Tscherne, Rebecca Jane Cox, Florian Krammer, Anders Madsen · 2026 · Influenza and Other Respiratory Viruses
73. T-cell-mediated immunity to influenza A (H2N3): implications for caccine efficacy and cross-subtype protection
    Jialu Huang, Qi Sun, Yuan Zhong, Junqiong Huang · 2026 · Archives of Microbiology
74. Beyond strain-specific immunity: Conserved antigenic targets, emerging platforms, and translational challenges in universal influenza and pan-coronavirus vaccine development
    Taruna Ikrar, Wachyudi Muchsin, Alfi Sophian · 2026 · Journal of Virological Methods
75. Pre-existing and cross-reactive immunity to avian influenza H5N1 in humans: Implications for pandemic risk and vaccine strategies
    Iván Sanz-Muñoz, Carlos J. Ciria-Gil, Marta Hernandez, César A. Santiago, Ahmed M. Elsayed, José M. Eiros, Luis Martínez‐Sobrido, Aitor Nogales · 2026 · Journal of Infection
76. Estimating the Relative Vaccine Efficacy of mRNA-1010 to High-Dose Influenza Vaccine in Adults ≥65 Years Using a Correlate of Protection Framework
    Van Hung Nguyen, Ethan C. Settembre, John E. Youhanna, Ekkehard C. Beck, Nicolas Van de Velde, Keya Joshi · 2026 · Vaccines
77. Nasal vaccination using novel mucosal adjuvants : with main focus on influenza A virus
    Tina Falkeborn · 2015 · Linköping University Electronic Press eBooks
78. Evaluation of Mismatched Immunity Against Influenza Viruses
    Ami R. Patel, Gary P Kobinger · 2012 · Future Virology
79. Viral Specific Cd8+ T Lymphocyte Immunity Provides Protection Against Heterotypic Stains Of Avian Influenza Viruses And Avian Coronaviruses
    Shailbala Singh, Jianwu Pei, Ellen Whited Collisson · 2014
80. Towards Future T Cell-Mediated Influenza Vaccines
    Thi H. O. Nguyen, Marios Koutsakos, Emma J. Grant, Peter C. Doherty, Katherine Kedzierska · 2016
81. Inter-Clade Protection Offered by Mw-Adjuvanted Recombinant HA, NP Proteins, and M2e Peptide Combination Vaccine in Mice Correlates with Cellular Immune Response
    Nilesh B. Ingle, Rashmi Virkar, Vidya Avinash Arankalle · 2017 · Frontiers in Immunology
82. H5N1 Protection by Seasonal Influenza Vaccine in Homologous and Heterologous Prime/Boost Vaccination
    Anna Roos, Ramon Roozendaal · 2015 · Journal of Vaccines & Vaccination
83. Immunosenescence Modulation by Vaccination
    Janet E. McElhaney · 2017 · Springer eBooks
84. Cytokine Profiling in COVID-19 Patients in a Tertiary Hospital in Saudi Arabia; the Pre-Storm Phase
    Mayyadah H. Alabdely, Walter Conca, Morad Ahmed Alkaff, Aziza Alonaizie, Futwan A Al-Mohanna, Futwan A Al-Mohanna, Walter Conca, Walter Conca, Walter Conca · 2022 · International Journal of Coronaviruses
85. A Mixture of T-Cell Epitope Peptides Derived from Human Respiratory Syncytial Virus F Protein Conferred Protection in DR1-TCR Tg Mice
    Hong Guo, Yang Song, Hai Li, Hongqiao Hu, Yuqing Shi, Jie Jiang, Jinyuan Guo, Lei Cao, Naiying Mao, Yan Zhang · 2024 · Vaccines
86. Advances in virus-host interaction research based on microfluidic platforms
    Cheng Wang, Ji Wang, Dong Liu, Zhiling Zhang · 2024 · Chinese Chemical Letters
87. Development of Influenza-Specific CD4 T Cell-Mediated Immunity in Children Following Inactivated Influenza Vaccination
    Ian Shannon, Nelson Huertas, Chantelle L. White, Hongmei Yang, Jennifer Lynn Nayak · 2024 · Journal of the Pediatric Infectious Diseases Society
88. Antiviral CD4+ T and myeloid cell responses to influenza vaccines are attenuated in older adults
    Jared M. Oakes, Joshua Simmons, Cindy Hager Nochowicz, Leslie A. Kirk, Joan Eason, Natasha Halasa, H. Keipp Talbot, Samuel S. Bailin, Jessica L. Castilho, Spyros A. Kalams · 2026 · Communications Medicine
89. To proceed or delay? The dilemma of community-acquired respiratory viruses in adults and pediatrics before allogeneic stem cell transplantation and chimeric-antigen-receptor T-cell therapy
    José Luís Piñana, Rodrigo Martino, Simone Cesaro, Diana Averbuch, Per Lujgman · 2025 · Current Opinion in Infectious Diseases
90. Heterogeneity of T Cell Responses to Pandemic pH1N1 Monovalent Vaccine in HIV-Infected Pregnant Women
    Adriana Weinberg, Petronella Muresan, Kelly Richardson, Terence Fenton, Teresa Dominguez, A. Anthony Bloom, D. Heather Watts, Mark J. Abzug, Sharon Nachman, Myron J. Levin et al. · 2015 · AIDS Research and Human Retroviruses
91. Review of the British Thoracic Society Winter Meeting 2013, 4–6 December, London, UK
    James Duncan Chalmers, Neil J. Greening, Ricardo Jorge Paixão José, Sam M. Janes · 2014 · Thorax
92. Induction profiles of mRNA of toll like receptors and cytokines in chickens pre-exposed to low pathogenic avian influenza H9N2 virus followed by challenge with highly pathogenic avian influenza H5N1 virus
    Sandeep Kumar Dash, Manoj Kumar, Jag Mohan Kataria, S. Nagarajan, Chakradhar Tosh, Harshad Vinayakrao Murugkar, Katherukamem Rajukumar, Semmannan Kalaiyarasu, Dhanapal Senthil Kumar, Diwakar D. Kulkarni · 2018 · Microbial Pathogenesis
93. On Setting Expectations for a Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine
    David H. Canaday, Stefan Gravenstein · 2020 · Clinical Infectious Diseases
94. Correction: A Dominant EV71-Specific CD4+ T Cell Epitope Is Highly Conserved among Human Enteroviruses
    Ruicheng Wei, Chunfu Yang, Mei Zeng, Frances E. Terry, Kai Zhu, Chunhui Yang, Ralf Marius Altmeyer, William D Martin, Anne Searls De Groot, Qibin Leng · 2014 · PLoS ONE
95. Quantifying the efficacy of influenza vaccines: Authors' reply
    Michael T. Osterholm, Nicholas S. Kelley, Alfred H. Sommer, Edward A. Belongia · 2012 · The Lancet Infectious Diseases
96. Improving seasonal influenza vaccination for older adults
    Graham Pawelec, Janet E. McElhaney · 2021 · Immunity & Ageing
97. Type II alveolar cells with constitutive expression of MHCII and limited antigen presentation capacity contribute to improved respiratory viral disease outcomes
    Sushila A. Toulmin, Chaitali Bhadiadra, Andrew J. Paris, Jeffrey H. Lin, Jeremy B. Katzen, Maria Ciocca Basil, Edward E. Morrisey, George Scott Worthen, Laurence Crane Eisenlohr · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
98. Pre-existing and post-COVID-19 immune responses to SARS-CoV-2 in cancer patients
    Tatjana Bilich, Malte Roerden, Yacine Maringer, Annika Nelde, Jonas S. Heitmann, Marissa Lisa Dubbelaar, Andreas Peter, Sebastian Hörber, Jens Bauer, Jonas Rieth et al. · 2021 · Research Square
99. mRNA Vaccines: A Prospective Analysis of Long-term, Multi-target, and Autoimmune Disorders
    Sarfaraz K. Niazi · 2023 · Preprints.org
100. Using models to identify the causes of pre-symptomatic transmission from human infection data
     Kayla Zhang, Damie Pak, Megan A. Greischar · 2024 · medRxiv